Search

Your search keyword '"Peacock, Andrew"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Peacock, Andrew" Remove constraint Author: "Peacock, Andrew" Publisher elsevier Remove constraint Publisher: elsevier
Sorry, I don't understand your search. ×
24 results on '"Peacock, Andrew"'

Search Results

2. Contributor contact details

Catalog

Books, media, physical & digital resources

3. Short-term hemodynamic effects of apelin in patients with pulmonary arterial hypertension

4. The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial Hypertension.

5. Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial.

6. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.

7. I cannot live without air conditioning! The role of identity, values and situational factors on cooling consumption patterns in India.

8. Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.

9. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

10. Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.

11. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.

12. Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study.

13. Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.

14. Imaging right ventricular function to predict outcome in pulmonary arterial hypertension.

15. Long-term safety and efficacy of imatinib in pulmonary arterial hypertension.

16. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension.

17. LA volume by CMR distinguishes idiopathic from pulmonary hypertension due to HFpEF.

19. Effects of frozen storage and sample temperature on water compartmentation and multiexponential transverse relaxation in cartilage.

20. The relationship between the components of pulmonary artery pressure remains constant under all conditions in both health and disease.

21. Prognostic impact of pulmonary arterial hypertension: a population-based analysis.

22. Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension.

23. Pulmonary artery pressure in healthy subjects at 4250 m measured by Doppler echocardiography.